期刊文献+

RNA干扰介导的MN9D细胞中α-synuclein表达抑制及其对细胞活力的影响(英文)

RNA interference mediated silencing of α-synuclein in MN9D cells and its effects on cell viability
下载PDF
导出
摘要 目的使用载体介导的RNA干扰(RNA interference,RNAi)方法抑制MN9D细胞中的α-synuclein基因表达,并检测其对细胞增殖和活力的影响。方法在α-synuclein的开放读码区选择两段19个核苷酸的片断,并选择一段与小鼠基因无同源性的阴性对照序列,分别设计合成单链寡核苷酸,退火融合成双链寡核苷酸。将双链寡核苷酸克隆入pENTR/H1/TO质粒载体,鉴定正确后,转染MN9D细胞,通过筛选获得稳定的细胞克隆。使用RT-PCR、Real-timePCR、免疫细胞化学染色和Westernblot方法检测细胞内的α-synuclein的表达水平,鉴定RNAi的效率。利用生长曲线和MTT法分别检测比较各组细胞的增殖和活力。结果转染pSH2/α-SYN的细胞与正常和转染pSH/CON的MN9D细胞相比,α-synuclein mRNA及蛋白水平均明显减少;而转染pSH1/α-SYN的细胞α-synuclein mRNA及蛋白水平与两组对照细胞没有明显差别。抑制α-synuclein表达不影响细胞增殖,但可以降低细胞活力。结论结果表明,SH2/α-SYN是有效的小干扰RNA(small interfering RNA,siRNA)序列,通过载体介导的RNAi方法可以有效抑制MN9D细胞中的α-synuclein表达,这为进一步研究α-synuclein蛋白的生理功能及其在帕金森病(Parkinson’s disease,PD)发病中的作用提供了良好的细胞模型;α-synuclein在维持MN9D细胞活力中起到重要作用,α-synuclein功能缺失会导致细胞直接或间接的损伤。 Objective To silence the expression of α-synuclein in MN9D dopaminergic cells using vector mediated RNA interference (RNAi) and examined its effects on cell proliferation and viability. Methods We identified two 19-nucleotide stretches within the coding region of the α-synuclein gene and designed three sets of oligonucleotides to generate doublestranded (ds) oligos. The ds oligos were inserted into the pENTR^TM/Hl/TO vector and transfected into MN9D dopaminergic cells, α-Synuclein expression was detected by RT-PCR, real-time PCR, immunocytochemistry staining and Western blot. In addition, we measured cell proliferation using growth curves and cell viability by 3-(4, 5)-dimethylthiahiazo (-z-y 1)-3, 5-diphenytetrazoliumromide (M'FF). Results The mRNA and protein levels of α-synuclein gene were significantly down-regulated in pSH2/α-SYN-transfected cells compared with control MN9D and pSH/CON-transfected MN9D cells, while pSHI/α-SYN- transfected cells showed no significant difference. Silencing α-synuclein expression does not affect cell proliferation but may decrease cell viability. Conclusion Our results demonstrated pSH2/α-SYN is an effective small interfering RNA (siRNA) sequence and potent silencing of mouse α-synuclein expression in MN9D cells by vector-based RNAi, which provides the tools for studying the normal function of α-synuclein and examining its role in Parkinson's disease (PD) pathogenesis. α-Synuclein may be important for the viability of MN9D cells, and loss of α-synuclein may induce cell injury directly or indirectl
出处 《Neuroscience Bulletin》 SCIE CAS CSCD 2008年第2期96-104,共9页 神经科学通报(英文版)
关键词 Α-SYNUCLEIN RNA干扰 帕金森病 α-Synuclein RNA interference Parkinson's disease
  • 相关文献

参考文献51

  • 1Recchia A, Debetto P, Negro A, Guidolin D, Skaper SD, Giusti E Alpha-synuclein and Parkinson's disease. FASEB J 2004, 18: 617-626.
  • 2Martin FL, Williamson S J, Paleologou KE, Allsop D, El-Agnaf OM. Alpha-synuclein and the pathogenesis of Parkinson's disease.Protein Pept Lett 2004, 11: 229-237.
  • 3Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997, 276: 2045- 2047.
  • 4Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 1998, 18: 106-108.
  • 5Greenbaum EA, Graves CL, Mishizen-Eberz AJ, Lupoli MA, Lynch DR, Englander SW, et al. The E46K mutation in α- synuclein increases amyloid fibril formation. J Biol Chem 2005, 280: 7800-7807.
  • 6Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. α-synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
  • 7Chan P, Tanner CM, Jiang X, Langston JW. Failure to find the α-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease. Neurology 1998, 50: 513-514.
  • 8Chart P, Jiang X, Fomo LS, Di Monte DA, Tanner CM, Langston JW. Absence of mutations in the coding region of the α-synuclein gene in pathologically proven Parkinson's disease. Neurology 1998, 50: 1136-1137.
  • 9Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. α-synuclein in Lewy bodies. Nature 1997, 388: 839- 840.
  • 10Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 1998, 95: 6469-6473.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部